ɪn noʊvˈɛmbɚ nˈaɪntiːnhˈʌndɹɪd nˈaɪnti sˈɪks, ðɪ ˌɛfdˌiːˈeɪ ˈɔːlsoʊ ɐpɹˈuːvd sˈɑːɹɡɹɐmˌoʊstɪm fɔːɹ tɹˈiːtmənt ʌv fˈʌŋɡəl ɪnfˈɛkʃənz ænd ɹᵻplˈɛnɪʃmənt ʌv wˈaɪt blˈʌd sˈɛlz fˈɑːloʊɪŋ kˌiːmoʊθˈɛɹəpi.
In November 1996, the FDA also approved sargramostim for treatment of fungal infections and replenishment of  white blood cells following chemotherapy.